RX-37 is a selective bromodomain and extraterminal (BET) inhibitor that targets BET bromodomain proteins, including BRD2, BRD3, and BRD4, with Ki values ranging from 3.2 to 24.7 nM. This compound demonstrates significant potential in cancer research by modulating gene expression pathways associated with oncogenesis. RX-37 is suitable for studies focused on the role of BET proteins in tumor biology and therapeutic interventions.
RX-37 is a selective bromodomain and extraterminal (BET) inhibitor that targets BET bromodomain proteins, including BRD2, BRD3, and BRD4, with Ki values ranging from 3.2 to 24.7 nM. This compound demonstrates significant potential in cancer research by modulating gene expression pathways associated with oncogenesis. RX-37 is suitable for studies focused on the role of BET proteins in tumor biology and therapeutic interventions.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
